Condition: Trigeminal Neuralgia · Sponsor: Stanford University
A randomized controlled trial comparing Onabotulinumtoxin A to saline (placebo) for Trigeminal Neuralgia.
This description comes directly from the study's public registry record.
Meredith Barad, MD · 6507217218 · nlariyos@stanford.edu
Natali Ariyoshi · 6504978821 · nlariyos@stanford.edu
Always discuss trial participation with your own doctor first.
| Meredith Barad | Stanford, California, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06216886